Sort
130,381 grants matching “hiv”
HIV Persistence During Suppressive Antiretroviral Therapy
$1,058,789Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pediatric HIV/AIDS Cohort Study (PHACS) Coordinating Center (CC) (U01)
$1,058,764Russell Barrett Van Dyke · Tulane University Of Louisiana · U01 · FY2018 · HD
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA
$1,058,587Johns Hopkins University · R01 · FY2000 · AI
Assessment of Infant Outcomes After in Utero Exposure to Antiretroviral Therapy
$1,058,509Sonia Hernandez-Diaz · Harvard School Of Public Health · R01 · FY2009 · HD
NJMS Clinical Trials Unit: Targeting Pediatric, Adolescent, and Material HIV Infe
$1,058,279James Oleske · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2007 · AI
HIV Persistence During Suppressive Antiretroviral Therapy
$1,058,277Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Anti-HIV-1 Composite Cellulose Acetate Phthalate Film
$1,057,967Shibo Jiang · New York Blood Center · U19 · FY2008 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,057,931Nancy Jo Hansen · Nebraska St Dept Of Health & Human Servs · U62 · FY2014 · PS
Streamlined Treatment and Evidence-based Adolescent counseling and Medication Support (STREAMS)
$1,057,586Philip Kreniske · Graduate School Of Public Health And Health Policy · R01 · FY2025 · MH
Immune mechanisms that shape the blood brain barrier in people living with HIV and cocaine use disorder
$1,057,519Rebecca Terilli Veenhuis · Johns Hopkins University · R01 · FY2024 · DA
THIRTY YEAR FOLLOW-UP OF NEGLECTED CHILDREN
$1,057,514Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2004 · HD
HERPESVIRUSES AS VACCINE VECTORS FOR AIDS
$1,057,488Harvard University (Medical School) · P01 · FY2001 · AI
Production Development
$1,057,404Niranjan Y Sardesai · Wistar Institute · U19 · FY2017 · AI
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$1,057,333Douglas K Owens · Stanford University · R37 · FY2021 · DA
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$1,057,149Chung-Chou Ho Chang · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
The effects of opioid use on HIV-1 reservoir dynamics
$1,057,122Athe M. Tsibris · Brigham And Women'S Hospital · R61 · FY2019 · DA
Antiviral Activity In Situ
$1,057,042Georgia D Tomaras · Duke University · P01 · FY2025 · AI
AIDS International Training and Research Program (AITRP)
$1,057,030Arthur L. Reingold · University Of California Berkeley · D43 · FY2007 · TW
NextGen Long-acting and targeted combination ART for Children with HIV
$1,056,967Rodney J.y. Ho · University Of Washington · R61 · FY2021 · AI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial
$1,056,953Christina Yoon · University Of California, San Francisco · R33 · FY2023 · HL
Tracking HIV Infection and Alcohol Abuse CNS Comorbidity with Neuroimaging
$1,056,910Adolf Pfefferbaum · Sri International · U01 · FY2013 · AA
Theoretically Based Mobile App to Increase PrEP Uptake Among MSM
$1,056,711Patrick Sean Sullivan · Emory University · R01 · FY2020 · DA
Monitoring SIV Reservoirs with Whole Body immunoPET
$1,056,530Francois J Villinger · University Of Louisiana At Lafayette · R01 · FY2018 · AI
Aurum Clinical Trials Unit
$1,056,434Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2021 · AI
Development of Vaccines to Prevent Tuberculosis
$1,056,433Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI